title: Everolimus-induced tubular toxicity in non-renal cancer.
authors.affiliation: Cancer Care Services, Redcliffe Hospital, Brisbane, Queensland, Australia.|Kidney Health Service, Royal Brisbane and Women's Hospital, Metro North Hospital Health Service, Brisbane, Queensland, Australia.|School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
authors.forename: S
authors.initials: S
authors.lastname: Chan
authors.affiliation: Department of Pathology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
authors.forename: L P
authors.initials: LP
authors.lastname: Francis
authors.affiliation: Kidney Health Service, Royal Brisbane and Women's Hospital, Metro North Hospital Health Service, Brisbane, Queensland, Australia.|School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
authors.forename: A L
authors.initials: AL
authors.lastname: Kark
authors.affiliation: Cancer Care Services, Redcliffe Hospital, Brisbane, Queensland, Australia.|School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
authors.forename: K J
authors.initials: KJ
authors.lastname: Bigby
authors.affiliation: Kidney Health Service, Royal Brisbane and Women's Hospital, Metro North Hospital Health Service, Brisbane, Queensland, Australia.
authors.forename: H G
authors.initials: HG
authors.lastname: Healy
authors.affiliation: Cancer Care Services, Redcliffe Hospital, Brisbane, Queensland, Australia.|School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
authors.forename: B W
authors.initials: BW
authors.lastname: Chern
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary*; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy*; D059248:Chemoradiotherapy / Q000379:methods; D000068338:Everolimus / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006615:Hip / Q000473:pathology*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D007687:Kidney Tubules, Proximal / Q000187:drug effects*; D008408:Mastectomy; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D013629:Tamoxifen / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D000068338:Everolimus